Wet AMD 3 Symposium

Related

• 

  Types of Strokes Seen in Patients

  Sophie Jane Bakri, MD

  Updates from the Field

  2017

• 

  FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

  Ivan J. Suner, MD, MBA

  Annual Meeting Talks

  2019

• 

  Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process

  Raj K. Maturi, MD

  Updates from the Field

  2019